X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26930) 26930
Newsletter (485) 485
Magazine Article (93) 93
Newspaper Article (57) 57
Book Chapter (39) 39
Dissertation (22) 22
Streaming Video (8) 8
Transcript (6) 6
Book Review (4) 4
Conference Proceeding (4) 4
Journal / eJournal (4) 4
Publication (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19177) 19177
male (12120) 12120
female (11772) 11772
methylprednisolone - therapeutic use (10115) 10115
methylprednisolone (9218) 9218
adult (7985) 7985
middle aged (6955) 6955
methylprednisolone - administration & dosage (6810) 6810
animals (4509) 4509
treatment outcome (3865) 3865
aged (3780) 3780
corticosteroids (3574) 3574
adolescent (3129) 3129
methylprednisolone - pharmacology (2598) 2598
drug therapy, combination (2566) 2566
anti-inflammatory agents - therapeutic use (2529) 2529
surgery (2517) 2517
child (2453) 2453
glucocorticoids - therapeutic use (2381) 2381
clinical neurology (2268) 2268
immunosuppressive agents - therapeutic use (2072) 2072
time factors (1982) 1982
rats (1850) 1850
methylprednisolone - adverse effects (1842) 1842
therapy (1790) 1790
glucocorticoids - administration & dosage (1723) 1723
medicine, general & internal (1649) 1649
follow-up studies (1640) 1640
steroids (1630) 1630
anti-inflammatory agents - administration & dosage (1621) 1621
transplantation (1565) 1565
retrospective studies (1557) 1557
magnetic resonance imaging (1498) 1498
immunology (1495) 1495
child, preschool (1359) 1359
pediatrics (1338) 1338
care and treatment (1332) 1332
rheumatology (1311) 1311
acute disease (1239) 1239
neurosciences (1225) 1225
dose-response relationship, drug (1215) 1215
prospective studies (1156) 1156
methylprednisolone - analogs & derivatives (1119) 1119
children (1114) 1114
medicine & public health (1098) 1098
research (1064) 1064
pharmacology & pharmacy (1050) 1050
injections, intravenous (1041) 1041
prednisone - therapeutic use (1039) 1039
dexamethasone (1029) 1029
drug administration schedule (983) 983
hematology (978) 978
glucocorticoids (970) 970
drug therapy (956) 956
recurrence (948) 948
prognosis (943) 943
administration, oral (922) 922
disease (915) 915
cyclophosphamide - therapeutic use (907) 907
diagnosis, differential (902) 902
biopsy (881) 881
urology & nephrology (862) 862
diagnosis (850) 850
health aspects (848) 848
young adult (841) 841
azathioprine - therapeutic use (835) 835
management (829) 829
inflammation (828) 828
ophthalmology (824) 824
analysis (820) 820
multiple sclerosis (810) 810
infant (808) 808
infusions, intravenous (805) 805
cyclophosphamide (800) 800
oncology (795) 795
risk factors (790) 790
adrenal cortex hormones - therapeutic use (786) 786
disease models, animal (780) 780
prednisolone (780) 780
pulse therapy, drug (773) 773
double-blind method (770) 770
kidney transplantation (762) 762
immunosuppressive agents - administration & dosage (758) 758
immunosuppression (757) 757
prednisolone - therapeutic use (757) 757
double-blind (753) 753
cyclosporine - therapeutic use (750) 750
aged, 80 and over (745) 745
patients (739) 739
prednisolone - administration & dosage (717) 717
combined modality therapy (707) 707
dosage and administration (694) 694
abridged index medicus (685) 685
dogs (678) 678
spinal cord injury (677) 677
orthopedics (664) 664
severity of illness index (658) 658
cyclophosphamide - administration & dosage (644) 644
high-dose methylprednisolone (624) 624
tomography, x-ray computed (617) 617
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24263) 24263
Japanese (1021) 1021
German (694) 694
French (631) 631
Spanish (395) 395
Italian (253) 253
Chinese (214) 214
Russian (151) 151
Polish (120) 120
Portuguese (75) 75
Korean (50) 50
Turkish (46) 46
Danish (44) 44
Czech (37) 37
Hungarian (32) 32
Dutch (26) 26
Norwegian (20) 20
Swedish (15) 15
Finnish (14) 14
Bulgarian (11) 11
Croatian (11) 11
Serbian (11) 11
Romanian (8) 8
Hebrew (7) 7
Afrikaans (5) 5
Lithuanian (3) 3
Slovak (3) 3
Ukrainian (3) 3
Persian (2) 2
Slovenian (2) 2
Arabic (1) 1
Belarusian (1) 1
Bosnian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 16, pp. 1671 - 1684
Journal Article
Journal of neurotrauma, ISSN 1557-9042, 2015, Volume 32, Issue 21, pp. 1674 - 1683
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 2018, Volume 84, Issue 5, pp. 1020 - 1028
Aims Intravenous high‐dose free methylprednisolone (MP) hemisuccinate is the primary treatment for an acute relapse in relapsing–remitting multiple sclerosis.... 
methylprednisolone | liposomes | multiple sclerosis | RELAPSES | COMPLEMENT | ACTIVATION | PLACEBO | GLUCOCORTICOIDS | INTRAVENOUS METHYLPREDNISOLONE | MODEL | PHARMACOKINETICS | THERAPEUTIC-EFFICACY | PHARMACOLOGY & PHARMACY | Methylprednisolone - pharmacokinetics | Humans | Male | Methylprednisolone - adverse effects | Polyethylene Glycols - chemistry | Healthy Volunteers | Dose-Response Relationship, Drug | Osteocalcin - blood | Drug Therapy, Combination - adverse effects | Anti-Inflammatory Agents - adverse effects | Delayed-Action Preparations - pharmacology | Delayed-Action Preparations - pharmacokinetics | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Adrenocorticotropic Hormone - blood | Methylprednisolone - chemistry | Double-Blind Method | Drug Administration Schedule | Drug Compounding - methods | Blood Glucose | Liposomes - adverse effects | Anti-Allergic Agents - therapeutic use | Cross-Over Studies | Liposomes - chemistry | Anti-Inflammatory Agents - chemistry | Methylprednisolone - pharmacology | Lymphocyte Count | Glutathione - chemistry | Clemastine - therapeutic use | Liposomes - pharmacology | Liposomes - pharmacokinetics | Antihistamines | Multiple sclerosis | Thiols | Corticosteroids | Lymphocytes | Analysis | ACTH | Methylprednisolone | Steroids | Index Medicus | Therapeutics
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2015, Volume 2015, Issue 8, p. CD001430
Background Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost... 
Acute Disease | Dexamethasone | Injections, Intravenous | Glucocorticoids | Administration, Oral | Optic Neuritis | Prednisone | Methylprednisolone | Visual Acuity | Randomized Controlled Trials as Topic | Optic nerve disease | Anti‐Inflammatory Agents | Eyes & vision | Medicine General & Introductory Medical Sciences | Contrast Sensitivity | TREATMENT-TRIAL | Humans | Male | FOLLOW-UP | RECOVERY | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE METHYLPREDNISOLONE | MULTIPLE-SCLEROSIS | Female | Anti-Inflammatory Agents [administration & dosage; therapeutic use] | VISUAL-FIELD PROFILE | Prednisone [administration & dosage; therapeutic use] | Methylprednisolone [administration & dosage; therapeutic use] | Dexamethasone [administration & dosage; therapeutic use] | Contrast Sensitivity [drug effects] | Optic Neuritis [drug therapy] | INJECTION | EXPERIENCE | Visual Acuity [drug effects] | Glucocorticoids [administration & dosage; therapeutic use] | FUNCTION QUESTIONNAIRE | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Methylprednisolone - therapeutic use | Dexamethasone - therapeutic use | Visual Acuity - drug effects | Optic Neuritis - drug therapy | Contrast Sensitivity - drug effects | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2017, Volume 318, Issue 5, pp. 432 - 442
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 10, p. CD001446
Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be... 
Guillain‐Barre Syndrome | Glucocorticoids | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Child health | Guillain‐Barré syndrome | Anti‐Inflammatory Agents | Adrenocorticotropic Hormone | Medicine General & Introductory Medical Sciences | Prednisolone | Corticosteroid treatment | GLOMERULONEPHRITIS | Methylprednisolone [administration & dosage; therapeutic use] | STEROIDS | Humans | Prednisolone [administration & dosage; therapeutic use] | Adrenocorticotropic Hormone [administration & dosage;therapeutic use] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | METHYLPREDNISOLONE | Guillain-Barre Syndrome [drug therapy] | TRIAL | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | PREDNISONE | THERAPY | STANDARD TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | Anti-Inflammatory Agents [administration & dosage;therapeutic use] | Adult | Glucocorticoids [administration & dosage; therapeutic use] | Child | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisolone - administration & dosage | Methylprednisolone - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Guillain-Barre Syndrome - drug therapy | Adrenocorticotropic Hormone - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisolone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 7, pp. e0130442 - e0130442
The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of... 
MYELIN BASIC-PROTEIN | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | MULTIPLE-SCLEROSIS | BARRIER PERMEABILITY | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | DOSE INTRAVENOUS METHYLPREDNISOLONE | SPINAL-CORD | BLOOD-BRAIN | VASCULAR-PERMEABILITY | Encephalomyelitis, Autoimmune, Experimental - metabolism | Nanoparticles - chemistry | Prodrugs - chemistry | Neurodegenerative Diseases - drug therapy | Apolipoproteins E - metabolism | Tissue Distribution | Inflammation - metabolism | Methylprednisolone Hemisuccinate - chemistry | Cyclic N-Oxides - pharmacology | Inflammation - drug therapy | Amyloid beta-Peptides - metabolism | Anti-Inflammatory Agents - pharmacokinetics | Disease Models, Animal | Multiple Sclerosis - metabolism | Anti-Inflammatory Agents - pharmacology | Methylprednisolone Hemisuccinate - pharmacokinetics | Methylprednisolone Hemisuccinate - pharmacology | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Neurodegenerative Diseases - metabolism | Cyclic N-Oxides - pharmacokinetics | Cyclic N-Oxides - chemistry | Liposomes - chemistry | Animals | Anti-Inflammatory Agents - chemistry | Prodrugs - pharmacokinetics | Mice | Drug Delivery Systems - methods | Prodrugs - pharmacology | Multiple Sclerosis - drug therapy | Drugs | Nervous system | Degeneration | Peptides | Apolipoproteins | Health aspects | Corticoids | Animal models | Multiple sclerosis | Drug delivery systems | Spinal cord | Nuclear magnetic resonance--NMR | Disease | Laboratories | Toxicity | Neuropathology | Biochemistry | Neurosurgery | Nitroxide | Drug development | Methylprednisolone |